Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study.
about
Allogeneic tumor cell vaccines: the promise and limitations in clinical trialsConcepts of immunotherapy for gliomaIdentification of patient-specific and tumor-shared T cell receptor sequences in renal cell carcinoma patientsInduction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccine.High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccinationAnti-leukemia T cells in AML: TNF-α⁺ CD8⁺ T cells may escape detection and possibly reflect a stage of functional impairment.Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study.The future of glioblastoma therapy: synergism of standard of care and immunotherapy.DC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional properties.Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB.
P2860
Q26852333-9405E4BD-9BC9-4E3F-92A9-C732BB7843FAQ28083888-0BEF58D9-9590-40BA-9C41-268202F583FCQ30313444-062AB439-28E6-446A-822C-32CA678F46E7Q33709802-31267C41-B6DE-450A-9FD9-E1DB2698A775Q36621785-293730B0-5D74-4CD3-B150-95AC5C749A24Q37514720-712C498A-C82A-42E9-BB5D-2EA0868A34D2Q37514725-233ACCA5-7854-4148-8EEA-68F877F7A12EQ38255481-84D40E8E-553E-4142-B550-3EAD81203A2EQ40007199-9E3DE135-19BE-4CDC-BCA3-2F96DEBECA86Q43963203-A59E3B92-C402-4DF1-90E0-AE13E71212BD
P2860
Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Allogeneic gene-modified tumor ...... cer: a clinical phase-I study.
@en
Allogeneic gene-modified tumor cells
@nl
type
label
Allogeneic gene-modified tumor ...... cer: a clinical phase-I study.
@en
Allogeneic gene-modified tumor cells
@nl
prefLabel
Allogeneic gene-modified tumor ...... cer: a clinical phase-I study.
@en
Allogeneic gene-modified tumor cells
@nl
P2093
P2860
P356
P1433
P1476
Allogeneic gene-modified tumor ...... cer: a clinical phase-I study.
@en
P2093
A Flörcken
A Lukowsky
A Pezzutto
A Takvorian
A van Lessen
C Schönemann
D J Schendel
G Willimsky
P2860
P2888
P304
P356
10.1038/GT.2010.143
P577
2010-11-11T00:00:00Z